Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
Seattle-based pre-clinical biotech Umoja Biopharma aims to revolutionise immunotherapy by retooling the patient’s immune system in vivo. Based on the…
Seattle-based pre-clinical biotech Umoja Biopharma aims to revolutionise immunotherapy by retooling the patient’s immune system in vivo. Based on the…
AstraZeneca has announced the voluntary withdrawal of the human monoclonal antibody Imfinzi (durvalumab) indication in the US for previously treated…
Research and development group of Eli Lilly and Company, Loxo Oncology at Lilly, and clinical-stage oncology company Merus have announced a research collaboration and exclusive…
The US Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Pfizer’s Xalkori (crizotinib) for treating paediatric patients aged one…
Boehringer Ingelheim has entered into a strategic collaboration and licensing agreement with Enara Bio to research and develop new targeted…
Pharmaceutical company Servier has signed an agreement to acquire Agios Pharmaceuticals’ oncology business including its commercial, clinical and research-stage oncology…
Boehringer Ingelheim has signed a binding agreement to acquire all shares of clinical-stage Swiss biotechnology company NBE-Therapeutics for a total…
Biopharmaceutical company Arcus Biosciences has expanded its existing strategic relationship with Chinese company WuXi Biologics to discover anti-CD39 antibodies using…
Quercis Pharma is working with the CRO Clinipace in a Phase III trial of Kinisoquin (isoquercetin) for venous thromboembolism (VTE)…
As of 29 January, the US likelihood of approval (LoA) for BeiGene’s Phase III anti-PD-1 antibody for esophageal squamous cell carcinoma (ESCC)…
R-Pharm, a Russian medical company, has announced they will be using fine micronisation technology from Swiss mill manufacturer Frewitt. The…
The way organizations have been connecting workers to the digital space is expensive, slow, and difficult for users. It also…
The global Covid-19 vaccines distribution task is a complicated operation and implementing an easy solution to monitor this process is…
As the biologics industry is moving towards more diverse batch volumes and cell concentrations that are cultivated in single-use facilities,…